Abstract
The first-line of treatment in the management of dry eye Sjogren’s syndrome patients is using artificial tears without preservatives and hyaluronic acid, which brings moisture to the ocular surface, preventing desiccation. However, recent findings suggest that dry eye is caused not only by the desiccation, but also by the lack of tear components. The second treatment regimen should include the supply of the tear components such as vitamin A and EGF to the ocular surface. The punctum plug is one choice of treatment when the patient has a minimal level of tear production. However, those patients who do not even produce even the smallest amount of tears, treatment by autologous serum eye drops becomes necessary. Serum has many components that exist in tears, so the 20% diluted autologous serum can be a good source of tear components for the ocular surface. In this chapter we focus on this tear component supply treatment.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Fox R. Sjögren’s syndrome: primer on the rheumatic diseases. Atlanta: Arthritis Foundation; 1998. pp. 283–286.
Tsubota K, Nakamori K. Dry eyes and video display terminals. N Engl J Med. 1993 Feb 25;328(8):584.
Xu KP, Yagi Y, Toda I, Tsubota K. Tear function index. A new measure of dry eye. Arch Ophthalmol. 1995 Jan;113(1):84–8.
Tsubota K, Xu KP, Fujihara T, Katagiri S, Takeuchi T. Decreased reflex tearing is associated with lymphocytic infiltration in lacrimal glands. J Rheumatol. 1996 Feb;23(2):313–20.
Kaido M, Goto E, Dogru M, Tsubota K. Punctal occlusion in the management of chronic Stevens–Johnson syndrome. Ophthalmology 2004 May;111(5):895–900.
Ono M, Takamura E, Shinozaki K, Tsumura T, Hamano T, Yagi Y, Tsubota K. Therapeutic effect of cevimeline on dry eye in patients with Sjögren’s syndrome: a randomized, double-blind clinical study. Am J Ophthalmol 2004 Jul;138(1):6–17.
Fox RI, Chan R, Michelson JB, Belmont JB, Michelson PE. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum. 1984 Apr;27(4):459–61.
Matsumoto Y, Dogru M, Goto E, Ohashi Y, Kojima T, Ishida R, Tsubota K. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology 2004 Jun;111(6):1115–20.
Kojima T, Ishida R, Dogru M, Goto E, Matsumoto Y, Kaido M, Tsubota K. The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case–control study. Am J Ophthalmol. 2005 Feb;139(2):242–6.
Kojima T, Higuchi A, Goto E, Matsumoto Y, Dogru M, Tsubota K. Autologous serum eye drops for the treatment of dry eye diseases. Cornea 2008;27:S25–30.
Tsubota K, Kaido M, Yagi Y, Fujihara T, Shimmura S. Diseases associated with ocular surface abnormalities: the importance of reflex tearing. Br J Ophthalmol. 1999 Jan;83(1):89–91.
Tsubota K. Reflex tearing in dry eye not associated with Sjogren’s syndrome. In: Sullivan D, et al., editors. Lacrimal gland, tear film and dry eye syndromes. 2nd ed. New York, NY: Plenum Press; 1998. pp. 903–907.
Tsubota K, Toda I, Yagi Y, Ogawa Y, Ono M, Yoshino K. Three different types of dry eye syndrome. Cornea 1994 May;13(3):202–9.
Ubels JL, Foley KM, Rismondo V. Retinol secretion by the lacrimal gland. Invest Ophthalmol Vis Sci. 1986 Aug;27(8):1261–8.
Ohashi Y, Motokura M, Kinoshita Y, Mano T, Watanabe H, Kinoshita S, Manabe R, Oshiden K, Yanaihara C. Presence of epidermal growth factor in human tears. Invest Ophthalmol Vis Sci. 1989 Aug;30(8):1879–82.
van Setten G, Viinikka L, Tervo T. EGF is a constant component of normal human tear fluid. Graefes Arch Clin Exp Ophthalmol. 1989:22:184–7.
van Setten GB, Tervo T, Tervo K, Tarkkanen A. Epidermal growth factor (EGF) in ocular fluids: presence, origin and therapeutical considerations. Acta Ophthalmol Suppl. 1992;(202):54–9.
Gupta A, Monroy D, Ji Z, Yoshino K, Huang A, Pflugfelder SC. Transforming growth factor beta-1 and beta-2 in human tear fluid. Curr Eye Res. 1996 Jun;15(6):605–14.
Nishida T, Ohashi Y, Awata T, Manabe R. Fibronectin. A new therapy for corneal trophic ulcer. Arch Ophthalmol. 1983 Jul;101(7):1046–8.
Nishida T, Nakamura M, Ofuji K, Reid TW, Mannis MJ, Murphy CJ. Synergistic effects of substance P with insulin-like growth factor-1 on epithelial migration of the cornea. J Cell Physiol. 1996 Oct;169(1):159–66.
Nishida T, Nakagawa S, Awata T, Tani Y, Manabe R. Fibronectin eye drops for traumatic recurrent corneal lesion. Lancet 1983 Aug 27;2(8348):521–2.
Tsubota K. New approaches in dry eye management: supplying missing tear components to the ocular surface epithelium. 1st Annual Meeting of the Kyoto Cornea Club. Amsterdam: Kugler. 1997; 1. pp. 27–32.
Tsubota K, Goto E, Fujita H, Ono M, Inoue H, Saito I, Shimmura S. Treatment of dry eye by autologous serum application in Sjögren’s syndrome. Br J Ophthalmol. 1999 Apr;83(4):390–5.
Speek AJ, van Agtmaal EJ, Saowakontha S, Schreurs WH, van Haeringen NJ. Fluorometric determination of retinol in human tear fluid using high-performance liquid chromatography. Curr Eye Res. 1986 Nov;5(11):841–5.
el-Ghorab M, Capone A Jr, Underwood BA, Hatchell D, Friend J, Thoft RA. Response of ocular surface epithelium to corneal wounding in retinol-deficient rabbits. Invest Ophthalmol Vis Sci. 1988 Nov;29(11):1671–6.
Noble BA, Loh RS, MacLennan S, Pesudovs K, Reynolds A, Bridges LR, Burr J, Stewart O, Quereshi S. Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol. 2004 May;88(5):647–52.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Tsubota, K. (2011). New Approaches for the Management of Dry Mouth and Dry Eye in Sjogren’s Syndrome in Japan. In: Fox, R., Fox, C. (eds) Sjögren’s Syndrome. Springer, New York, NY. https://doi.org/10.1007/978-1-60327-957-4_24
Download citation
DOI: https://doi.org/10.1007/978-1-60327-957-4_24
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-60327-956-7
Online ISBN: 978-1-60327-957-4
eBook Packages: MedicineMedicine (R0)